Eli Lilly Stock Slips as Lowered Profit Outlook Outweighs Solid Q1 Results
1. LLY reported strong Q1 earnings but cut profit forecasts. 2. Adjusted EPS forecast lowered to $20.17-$21.67 range. 3. Sales for Mounjaro and Zepbound rose significantly. 4. Company affirmed revenue guidance despite lower profit outlook. 5. Shares fell 4% following the earnings report.